These success, together with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two support the idea of focusing on ACKR3 as a singular solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated disorders.These outcomes suggest that conolidi